Patent US3485821A successfully refreshed from Google Patents.
Patent US4652529A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4652529A Expired / Lapsed US ⏱️ 0.0 years remaining

Serum pretreatment for tricyclic antidepressant drug assays

Assignee: Siemens Healthcare Diagnostics GmbH Germany
•
Filing: 1984-10-02
•
Granted: 1987-03-24
•
Expires: 2004-10-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Serum is passed through a column containing alkylated silica gel. The column is then washed with a mixture comprising from about 50 to 85 volume percent of an aqueous buffered medium of pH from about 3.5 to 5.0 and from about 15 to 50 volume percent of an organic solvent containing from 1 to 6 carbon atoms and from 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur. The tricyclic antidepressant drug is removed from the column with an eluent mixture comprising from about 0 to 75 volume percent of an aqueous buffered medium of pH of about from 6 to 8 and from about 25 to 100 volume percent of one or more organic solvents containing from 1 to 6 carbon atoms and from 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur. In this way, a tricyclic antidepressant drug sample, free from interfering metabolites, for use in assay determinations is obtained.

Inventors

  • 👤 Christine G. Collins
  • 👤 Susan Pankey
  • 👤 Anna Jaklitsch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 16:46
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/94; G01N33/9466; Y; Y10; Y10T; Y10T436/00; Y10T436/14; Y10T436/141111

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 237 words
A method for preparing a serum sample for determination of a tricyclic antidepressant drug in an assay, which method comprises: (a) adding said serum sample to a chromatographic column containing silica gel alkylated with alkyl groups of from 1 to 12 carbon atoms; (b) washing the column with a wash solution comprising from about 15 to 50 volume percent of a first organic solvent of from 1 to 6 carbon atoms and from 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur and from about 50 to 85 volume percent of an aqueous buffered medium having a pH of about from 3.5 to 5.0, in an amount sufficient to substantially remove metabolites of the tricyclic antidepressant drug from said column but insufficient to remove the tricyclic antidepressant drug from the column; and (c) eluting the tricyclic antidepressant drug with an elution solution comprising from about 25 to 100 volume percent of a second organic solvent of from 1 to 6 carbon atoms and 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur, wherein said second organic solvent may be the same or different than said first organic solvent, and from about 0 to 75 volume percent of an aqueous buffered medium having a pH of from about 6 to 8 in an amount sufficient to elute a substantial portion of the tricyclic antidepressant drug from the column.
Claim 2
Independent Claim 237 words
A method for preparing a serum sample for determination of a tricyclic antidepressant drug in an assay, which method comprises: (a) adding said serum sample to a chromatographic column containing silica gel alkylated with alkyl groups of from 1 to 12 carbon atoms; (b) washing the column with a wash solution comprising from about 15 to 50 volume percent of a first organic solvent of from 1 to 6 carbon atoms and from 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur and from about 50 to 85 volume percent of an aqueous buffered medium having a pH of about from 3.5 to 5.0, in an amount sufficient to substantially remove metabolites of the tricyclic antidepressant drug from said column but insufficient to remove the tricyclic antidepressant drug from the column; and (c) eluting the tricyclic antidepressant drug with an elution solution comprising from about 25 to 100 volume percent of a second organic solvent of from 1 to 6 carbon atoms and 1 to 5 heteroatoms selected from the group consisting of oxygen, nitrogen, and sulfur, wherein said second organic solvent may be the same or different than said first organic solvent, and from about 0 to 75 volume percent of an aqueous buffered medium having a pH of from about 6 to 8 in an amount sufficient to elute a substantial portion of the tricyclic antidepressant drug from the column.
Claim 3
Dependent Claim 21 words
The method of claim 1 wherein the silica gel is alkylated with alkyl groups of from 1 to 6 carbon atoms.
Claim 4
Dependent Claim 11 words
The method of claim 2 wherein said alkyl group is ethyl.
Claim 5
Dependent Claim 20 words
The method of claim 1 wherein at least one of said first and said second organic solvents is an alkylnitrile.
Claim 6
Dependent Claim 18 words
The method of claim 1 wherein at least one of said first and second organic solvents is acetonitrile.
Claim 7
Dependent Claim 21 words
The method of claim 1 wherein said aqueous buffered medium in Step b contains a metal salt of a carboxylic acid.
Claim 8
Dependent Claim 12 words
The method of claim 6 wherein said metal salt is sodium acetate.
Claim 9
Dependent Claim 25 words
The method of claim 1 wherein said aqueous buffered medium in Step b additionally contains an alkyl sulfonate of from 5 to 7 carbon atoms.
Claim 10
Dependent Claim 12 words
The method of claim 8 wherein said alkyl sulfonate is heptane sulfonate.
Claim 11
Dependent Claim 21 words
The method of claim 1 wherein said aqueous buffered medium in Step b has a pH of about 4.0 to 4.5.
Claim 12
Dependent Claim 17 words
The method of claim 1 wherein the amount of wash solution is about 0.8 to 1.0 ml.
Claim 13
Dependent Claim 17 words
The method of claim 1 wherein the amount of elution solution is about 0.5 to 1.0 ml.
Claim 14
Dependent Claim 29 words
The method of claim 1 wherein the elution solution in Step c comprises two different organic solvents in the ratio of about 1:1 by volume to 1:2 by volume.
Claim 15
Dependent Claim 15 words
The method of claim 13 wherein the organic solvents are an alkylnitrile and an alcohol.
Claim 16
Dependent Claim 13 words
The method of claim 13 wherein the organic solvents are acetonitrile and methanol.
Claim 17
Dependent Claim 18 words
The method of claim 1 wherein the aqueous buffered medium in Step c is an aqueous phosphate buffer.
Claim 18
Dependent Claim 24 words
The method of claim 1 wherein said tricyclic antidepressant drug is selected from the group consisting of amitriptyline, nortriptyline, impramine, desmethylimipramine, doxepin and desmethyldoxepin.
Claim 19
Dependent Claim 37 words
The method of claim 1 wherein in Step b the wash solution comprises from about 25 to 35 volume percent of the organic solvent and from about 65 to 75 volume percent of the aqueous buffered medium.
Claim 20
Dependent Claim 37 words
The method of claim 1 wherein in Step c the elution solution comprises from about 65 to 75 volume percent of the organic solvent and from about 25 to 35 volume percent of the aqueous buffered medium.

References Cited (Backward Citations)

US4223013A Cited
US4307245A Cited
US4275160A Cited
US4551275A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-23 1990-09-22 1991-03-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-23 1994-09-22 1995-03-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-23 1998-09-22 1999-03-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag